Neuroprotective Effects of Chaperonin Containing TCP1 Subunit 2 (CCT2) on Motor Neurons Following Oxidative or Ischemic Stress

  • 0Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung, 25457, South Korea.

|

|

Summary

This summary is machine-generated.

Tat-CCT2 fusion protein protects neurons from oxidative damage and spinal cord injury. This novel therapeutic agent reduces reactive oxygen species, DNA fragmentation, and inflammation, improving neurological function after ischemia.

Area Of Science

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background

  • Chaperonin containing TCP1 (CCT) is crucial for proteostasis, particularly CCT2's role in neurological disorders.
  • Limited research exists on CCT2's impact on spinal cord ischemic damage.
  • Neuronal death in neurological conditions highlights the need for protective strategies.

Purpose Of The Study

  • To investigate the neuroprotective effects of a cell-permeable Tat-CCT2 fusion protein.
  • To evaluate Tat-CCT2's efficacy against oxidative damage in vitro and ischemic injury in vivo.
  • To explore the underlying mechanisms of Tat-CCT2's protective action.

Main Methods

  • Synthesized a cell-permeable Tat-CCT2 fusion protein.
  • Assessed Tat-CCT2 delivery, localization, and degradation in NSC34 motoneuron-like cells.
  • Induced oxidative damage using H2O2 in vitro and ischemic injury in rabbit spinal cords.
  • Measured neuronal damage, reactive oxygen species, DNA fragmentation, neurological scores, cell survival, oxidative stress markers, and inflammatory cytokines.

Main Results

  • Tat-CCT2 efficiently entered NSC34 cells and rabbit spinal cords, with observed cytosolic localization and gradual degradation.
  • Tat-CCT2 significantly ameliorated H2O2-induced neuronal damage, reactive oxygen species, and DNA fragmentation in vitro.
  • In vivo, Tat-CCT2 treatment improved neurological scores, increased neuronal survival, and reduced oxidative stress, ferroptosis markers, and pro-inflammatory cytokines post-ischemia/reperfusion.
  • Tat-CCT2 also mitigated ischemia-induced microglial activation in the spinal cord.

Conclusions

  • Tat-CCT2 demonstrates significant neuroprotective effects against oxidative stress and ischemic injury in the spinal cord.
  • The fusion protein effectively penetrates target cells and tissues, offering a promising therapeutic avenue.
  • Tat-CCT2 mitigates neuronal damage by reducing oxidative stress, inflammation, and microglial activation, thereby improving functional recovery.